Deciphering the Role of ADAMTS6 in the Epithelial–Mesenchymal Transition of Lung Adenocarcinoma Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262411850 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Kirill V Odarenko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Adenocarcinoma of Lung, Lung Neoplasms, ADAMTS Proteins. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Russian state-funded project for ICBFM SB RAS.
Abstract (Originalsprache)
A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAMTS6) is an extracellular matrix (ECM) protease that promotes the invasion of lung adenocarcinoma (LUAD) cells. Herein, we investigate its role in epithelial-mesenchymal transition (EMT), a process that drives metastasis and drug resistance in LUAD. Re-analysis of microarray and RNA sequencing data from LUAD cells revealed that during EMT, TGF-β1 increased ADAMTS6 expression, presumably through the SMAD pathway, as SMAD2 loss completely blocked this effect. Moreover, ADAMTS6 was shown to occupy hub positions within TGF-β1-associated gene networks. Using additional datasets, we found that ADAMTS6 expression increased under other EMT-inducing conditions, including IL-1β induction and acquired gefitinib resistance, but decreased upon knockdown of Twist1, a master regulator of EMT. Knockout of ADAMTS6 repressed colony formation, migration, invasion, and doxorubicin resistance but enhanced cell–ECM adhesion in A549 cells. This effect was mediated by EMT inhibition, evidenced by upregulation of E-cadherin and downregulation of N-cadherin, vimentin, and Twist1, and was accompanied by suppressed nuclear translocation of the NF-κB p65 subunit. Re-analysis of transcriptomic data from patient tumors demonstrated that high ADAMTS6 expression correlated with the expression of EMT markers, further supporting the ADAMTS6–EMT link. Moreover, high ADAMTS6 expression was associated with worse survival prognosis. Overall, ADAMTS6 promotes EMT in LUAD cells and may be considered a marker of this process, as well as a potential therapeutic target for its inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
ORCID-Profile: Kirill V Odarenko, Grigory A Stepanov, Marina A Zenkova, Andrey V Markov
Förderung
- Russian Science Foundation
- Russian state-funded project for ICBFM SB RAS
Zitieren
APA
Odarenko, K. V., Matveeva, A. M., Stepanov, G. A., Zenkova, M. A., & Markov, A. V. (2025). Deciphering the Role of ADAMTS6 in the Epithelial–Mesenchymal Transition of Lung Adenocarcinoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411850
Vancouver
Odarenko KV, Matveeva AM, Stepanov GA, Zenkova MA, Markov AV. Deciphering the Role of ADAMTS6 in the Epithelial–Mesenchymal Transition of Lung Adenocarcinoma Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411850
BibTeX
@article{Odarenko2025,
author = {Odarenko, Kirill V and Matveeva, Anastasiya M and Stepanov, Grigory A and Zenkova, Marina A and Markov, Andrey V},
title = {Deciphering the Role of ADAMTS6 in the Epithelial–Mesenchymal Transition of Lung Adenocarcinoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262411850}
}
EUVIMED